Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- USANA Announces Strong Third Quarter Financial Results
Company reports net sales of $82.2 million, up 20% in the third quarter, compared with $68.7 million in the third quarter of 2004, with net earnings of of $10.0 million ($0.51 per share), an increase of 25.6%, compared with net earnings of $8.0 million ($0.39 per shre) in the third quarter of 2004.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Fortitech, Inc. Continues Corporate Growth With Key Staff Appointments
Fortitech, Inc., is pleased to announce the addition of Thomas Morba as its new purchasing manager.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Nu Skin Enterprises Chief Executive Appointed as Chairman of World Federation of Direct Selling Associations
The World Federation of Direct Selling Associations today announced the election of Nu Skin Enterprises (NUS) President and Chief Executive Officer Truman Hunt as chairman of its board of directors, effective immediately.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- Swiss Medica Announces Record Third Quarter Results
Company reports revenues of US$1.77 million compared to US$1.38 million prior year, including success with the company's O24 Pain Neutralizer and launch of PMS Escape in the United States.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- New Facility for Puresource and NOW Foods
The 11,000 sq ft plant has been developed to meet the current requirements for Natural Health Products Good Manufacturing Practices; Products marketed under the Herbal Select and NOW brands will be produced in this facility.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- Planet Organic Health Corp Announces Annual Sales Results
Company reports sales of $27.2 million for the year, compared to $12.1 million for the 12-month period last year, increase was driven by acquisitions, store expansions, and same-store sales growth.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- United Natural Foods Names Michael S. Funk Chief Executive Officer, to Succeed Steven H. Townsend
Company announces that Steven H. Townsend has announced his retirement and has resigned as President and Chief Executive Officer and that Michael S. Funk, a United Natural Foods Director, will assume the additional responsibilities of President and Chief Executive Officer.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Natural Alternatives International, Inc. Announces First Quarter Results
Company reports net income of $412,000 or $0.06 per diluted share on net sales of $21.7 million, compared to $852,000 or $0.13 per diluted share on net sales of $21.7 million prior year.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- Balchem Corporation Announces Third Quarter 2005 Results
Company reports net sales of $21.1 million and net earnings of $3.0 million ($0.37 per share) for the quarter, Sales of the Encapsulated/Nutritional Products segment were $8.5 million in the period, an increase of 30.7% from the prior year comparable quarter, slowness in nutritional supplement area noted.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- OrderDog Teams with SPINS to Dually Broaden Scope of Subscribers' Available Product, Consumer Information
Company announces partnership with SPINS (R), Inc. that will integrate the SPINS Product Library into OrderDog product database, giving OrderDog subscribers information on an additional 400,000 natural products.
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Royal DSM N.V. and North China Pharmaceutical Group Corporation announce next steps in their strategic partnership
The companies announced a further detailing agreement confirming the terms of further cooperation including the establishment of two joint ventures in the areas of nutritional products (especially Vitamin C and B12).
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Neptune Technologies & Bioressources Inc. Reports Results for Q1, 2005
Company reports sales and EBITDA reached $1,822,000 and $342,000 respectively for the quarter, with a loss of $390,000 or $0.015 per share.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- Nu Skin Enterprises Reports Third Quarter 2005 Results
Company reports revenue of $290.8 million, with net income of $17.7 million and earnings per share of $0.25, compared to income of $20.9 million and earnings per share of $0.29 for the same period prior year; Sales in Mainland China drop 10%.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- IFF Reports Third Quarter Results
Company reports sales of $493.1 million, declining 3% in comparison to the prior year with fragrance and flavor sales decreased 1% and 3%. Earnings per share were $.72 compared to $.44 in the prior year quarter.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Monsanto, Solae Collaborate to Develop New Soy Proteins
Monsanto and The Solae Company today announced an agreement to develop and market a new line of soy proteins with improved flavor and solubility.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Advitech Announces Third-Quarter Financial Results
Company reports net loss stood at $1,735,545, or $0.03 per share, compared to a net loss of $921,094, or $0.02 per share for the same period in 2004.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Archer Daniels Midland Reports First Quarter Results
Company reports earnings of $186 million ($.29 per share) compared to $266 million ($.41 per share) last year, with operating profit increasing 3% to $351 million from $339 million last year.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Weider Nutrition International Announces Name Change to Schiff Nutrition International
Company announces its formal name change to Schiff Nutrition International, Inc.; will retain its current New York Stock Exchange symbol: WNI.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- Nutrition 21 Announces Supply & Licensing Agreement with CNS, Inc. for Chromax® Chromium Picolinate Inclusion in FiberChoice® Weight Management Chewable Tablets
Nutrition 21, Inc., (NASDAQ: NXXI) announced a supply & licensing agreement with CNS, Inc, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product FiberChoice Weight Management™ chewable tablets.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- B&D Nutritional Partners With C S Agra
B&D Nutritional Ingredients announces an exclusive marketing agreement with C S Agra of Louisville, KY. B&D Nutritional Ingredients will immediately roll out C S Agra’s proprietary broccoli sprout extract, sgs™-100.
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- iSatori Technologies Signs National Exclusive Distribution Agreement With Europa Sports Products
iSatori Technologies has again joined forces with Europa Sports Products, Inc., for national distribution of their entire line of physique and performance enhancement nutritional supplements
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results
Company reports sales for FY06 Q2 were 2,517,000, a decrease of 16% relative to sales of $2,998,000 for the same period of the prior fiscal year, with gross profit of $581,000, compared to a gross profit of $1,054,000 prior year.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- GNC Corporation Reports Third Quarter and First Nine Months 2005 Financial Results
Company reports consolidated revenues of $322.6 million for the third quarter ended September 30, 2005 compared to consolidated revenues of $323.1 million for the same quarter of the prior year, offsetting a 32.4% decline in the diet category in domestic company-owned locations with gains in sales of sports nutrition, herbs and vitamin products. Net Income for the third quarter ended September 30, 2005, was $3.2 million compared to $8.5 million for the third quarter of 2004.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Mr. Kobi Levy Appointed Executive Vice President and Manager of Frutarom's Global Flavors Division
Company announces that Mr. Kobi Levy has been appointed to the position of Executive Vice President of the global Frutarom Group and Manager of its Global Flavors Division.
- Nutrition 21 Reports First Quarter Fiscal 2006 Results
Company reports revenues of $3.60 million as compared to $2.74 million for the same quarter in fiscal 2005, with gross profit of $3.0 million and an operating loss of $0.8 million, an improvement of $0.4 million when compared to an operating loss of $1.2 million for the same period a year ago. Net loss for the quarter was $1.1 million or ($0.03) per diluted share compared to a net loss of $1.2 million or ($0.03) per diluted share for the same period last year.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Netherlands-based DSM has announced FY05 Q3 results, reporting net profit of EUR 151 million, up 25% from Q3 2004. The company projects operating profit(a) for the whole of 2005 will exceed EUR 800 million and will thus be substantially above 2004 results of EUR 567 million. The company posted a total Operating profit of EUR 220 million for Q3, up 44% from Q3 2004, due mainly to higher margins and lower fixed costs.
Net sales for DSM Nutritional Products rose from EUR 472 million to EUR 480 million for the quarter, with 9 month results showing net sales of EUR 1,426 million versus EUR 1,430 million for the 9 month period, prior year. DSM Food Specialties' profit increased due to higher sales volumes. |